Trial studies extended release Viramune.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019829:Nevirapine / Q000008:administration & dosage / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D003692:Delayed-Action Preparations; D019829:Nevirapine